Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan
· Delayed Price · Currency is TWD 78.50
-4.20 (-5.08%)
Apr 29, 2026, 2:00 PM CST
Steminent Biotherapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.51B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AnnJi Pharmaceutical | 7.55M |
| UnicoCell Biomed | 30.10M |
| Savior Lifetec | 1.20B |
| Panion & Bf Biotech | 2.06B |
| Mycenax Biotech | 740.24M |
| Sinphar Pharmaceutical | 3.37B |
| Pharmosa Biopharm | 67.27M |
| Medigen Biotechnology | 1.58B |